You are on page 1of 9

Hsiang JC, Bai WW, Raos Z, .

Epidemiology, disease burden and outcomes of cirrhosis in a large

secondary care hospital in South Auckland, New Zealand. Intern Med J. 2015;45:160–169.

Burra P. Hepatitis C. Semin Liver Dis. 2009;29:53–65.

Mokdad AA, Lopez AD, Shahraz S, . Liver cirrhosis mortality in 187 countries between 1980 and 2010:

a systematic analysis. BMC Med. 2014 Sep 18;12(1):145.

Chiang JL. (2014). Liver physiology: Metabolism and detoxification. Pathobiology of Human Disease,

pp. 1770-1782

Guengerich, F.P., Cheng, Q., 2011. Orphans in the human cytochrome P450 superfamily: approaches to

discovering functions and relevance in pharmacology. Pharmacol. Rev. 63, 684–699

Moore, M.C., Coate, K.C., Winnick, J.J., An, Z., Cherrington, A.D., 2012. Regulation of hepatic glucose

uptake and storage in vivo. Adv. Nutr. 3, 286–294.

Cohen, J.C., Horton, J.D., Hobbs, H.H., 2011. Human fatty liver disease: old questions and new insights.

Science 332, 1519–1523.

G. Vernon, A. Baranova, Z.M. Younossi, Systematic review: the epidemiology and natural history of

non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment. Pharmacol.

Ther. 34 (3) (2011) 274e285.

I.R. Wanless, J.S. Lentz, Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis

of risk factors, Hepatology 12 (5) (1990) 1106e1110

K. Bambha,. Ethnicity and nonalcoholic fatty liver disease, Hepatology 55 (3) (2012) 769e780.

M. Ekstedt, ., Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology 44

(4) (2006) 865e873.


Reddy JK, Rao MS. "Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid

xidation". Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 290: 852–8.

Goldman, Lee. Cecil Textbook of Medicine -- 2-Volume Set, Text with Continually Updated Online

ference. Philadelphia: W.B. Saunders Company; 2003.

Iredale JP. "Cirrhosis: new research provides a basis for rational and targeted treatments". BMJ; 2001:

327: 143–147.

Sembulingam K, sembulingam P. Liver and Gallblader, chapter 40 In: essentials of medical physiology,

3rd edition, jaypee brothers medical publishers (p)ltd: new delhi;2004. page no.200-201

Chien-Jen Chen, Hwai-I. Yang, Jun Su, Chin-Lan Jen, San-Lin You, Sheng-Nan Lu, Guan-Tarn Huang,

chenna H. Iloeje. "Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum

Hepatitis B Virus DNA Level". JAMA. 2006; 295: 65–73.

Polson J, Lee WM."AASLD position paper: the management of acute liver failure". Hepatology.2005;

41: 1179–97.

Dawkins MJ. Carbon tetrachloride poisoning in the liver of the new born rat. J.path.bact.1963; 85:189.

Ambrose A.M, DeEds F, Rather L.J. further studies on toxicity of thioacetamide in rats. Proc. Soc. Exp.

Boil. Med 1950; 74: 134-140.

Pandey A, Bigoniya P, Raj V, Patel K. Pharmacological screening of Coriandrum sativum Linn. for

hepatoprotective activity. J Pharm Bioall Sci 2011;3:435-41

de Vries J, de Jong J, Lock F, van Bree L,Mullink H, Veldhuizen R. Protection against paracetamol-

induced hepatotoxicity by acetylsalicylic acid in rats.Toxicology.1984; 30: 297-304


Apel, K.; Hirt, H. Reactive oxygen species: Metabolism, oxidative stress, and signal transduction. Annu.

Rev. Plant Biol. 2004, 55, 373–399. [CrossRef] [PubMed]

McCord, J.M. The evolution of free radicals and oxidative stress. Am. J. Med. 2000, 108, 652–659

Sanchez-Valle, V.; Chavez-Tapia, N.C.; Uribe, M.; Mendez-Sanchez, N. Role of oxidative stress and

molecular changes in liver fibrosis: A review. Curr. Med. Chem. 2012, 19, 4850–4860

Mallikarjuna, K.; Shanmugam, K.R.; Nishanth, K.; Wu, M.C.; Hou, C.W.; Kuo, C.H.; Reddy, K.S.

Alcohol-induced deterioration in primary antioxidant and glutathione family enzymes reversed

by exercise training in the liver of old rats. Alcohol 2010, 44, 523–529.

Tang, W.; Jiang, Y.F.; Ponnusamy, M.; Diallo, M. Role of Nrf2 in chronic liver disease. World J.

Gastroenterol. 2014, 20, 13079–13087

Klaassen, C.D.; Reisman, S.A. Nrf2 the rescue: Effects of the antioxidative/electrophilic response on the

liver. Toxicol. Appl. Pharmacol. 2010, 244, 57–65

Tang, W.; Jiang, Y.F.; Ponnusamy, M.; Diallo, M. Role of Nrf2 in chronic liver disease. World J.

Gastroenterol. 2014, 20, 13079–13087

Esrefoglu, M. Oxidative stress and benefits of antioxidant agents in acute and chronic hepatitis. Hepat.

Mon. 2012, 12, 160–167

Zhu, H.; Jia, Z.; Misra, H.; Li, Y.R. Oxidative stress and redox signaling mechanisms of alcoholic liver

disease: Updated experimental and clinical evidence. J. Dig. Dis. 2012, 13, 133–142.

Diehl, A.M. Recent events in alcoholic liver disease V. Effects of ethanol on liver regeneration. Am. J.

Physiol.-Gastrointest. Liver Physiol. 2005, 288, G1–G6.


Valente, M.J.; Carvalho, F.; Bastos, M.; de Pinho, P.G.; Carvalho, M. Contribution of oxidative

metabolism to cocaine-induced liver and kidney damage. Curr. Med. Chem. 2012, 19, 5601–560

Videla, L.A. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms.

World J. Hepatol. 2009, 1, 72–78.

Linares, V.; Alonso, V.; Albina, M.L.; Belles, M.; Sirvent, J.J.; Domingo, J.L.; Sanchez, D.J. Lipid

peroxidation and antioxidant status in kidney and liver of rats treated with sulfasalazine.

Toxicology 2009, 256, 152–156

Mladenovic, D.; Radosavljevic, T.; Ninkovic, M.; Vucevic, D.; Jesic-Vukicevic, R.; Todorovic, V. Liver

antioxidant capacity in the early phase of acute paracetamol-induced liver injury in mice. Food

Chem. Toxicol. 2009, 47, 866–870

Samarghandian, S.; Afshari, R.; Farkhondeh, T. Effect of long-term treatment of morphine on enzymes,

oxidative stress indices and antioxidant status in male rat liver. Int. J. Clin. Exp. Med. 2014, 7,

1449–1453.

Pieniazek, A.; Czepas, J.; Piasecka-Zelga, J.; Gwozdzinski, K.; Koceva-Chyla, A. Oxidative stress

induced in rat liver by anticancer drugs doxorubicin, paclitaxel and docetaxel. Adv. Med. Sci.

2013, 58, 104–111.

Sha Li, Hor-Yue Tan, NingWang, Zhang-Jin Zhang, Lixing Lao, Chi-WoonWong and Yibin Feng.The

Role of Oxidative Stress and Antioxidants in Liver Diseases. Int. J. Mol. Sci. 2015, 16, 26087–

26124
Mahantesh S.P., Gangawane A.K. and Patil C.S. 2012. Free Radicals, Antioxidants, Diseases And

Phytomedicines In Human Health: Future Perspects. World Research Journal Of Medicinal &

Aromatic Plants,1(1), 06-10

Frazier, T.H.; Stocker, A.M.; Kershner, N.A.; Marsano, L.S.; McClain, C.J. Treatment of alcoholic liver

disease. Ther. Adv. Gastroenterol. 2011, 4, 63–81

Diehl, A.M.; Chute, J. Underlying potential: Cellular and molecular determinants of adult liver repair. J.

Clin. Investig. 2013, 123, 1858–1860

Li, A.N.; Li, S.; Li, H.B.; Xu, D.P.; Xu, X.R.; Chen, F. Total phenolic contents and antioxidant capacities

of 51 edible and wild flowers. J. Funct. Foods 2014, 6, 319–330

Augustyniak, A.; Waszkiewicz, E.; Skrzydlewska, E. Preventive action of green tea from changes in the

liver antioxidant abilities of different aged rats intoxicated with ethanol. Nutrition 2005, 21, 925–

932.

Lirussi, F.; Azzalini, L.; Orando, S.; Orlando, R.; Angelico, F. Antioxidant supplements for non-

alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst. Rev. 2007, 24

Sattar, N.; Forrest, E.; Preiss, D. Non-alcoholic fatty liver disease. BMJ 2014, 349, 8.

Lee, J.H.; Friso, S.; Choi, S.W. Epigenetic mechanisms underlying the link between non-alcoholic fatty

liver diseases and nutrition. Nutrients 2014, 6, 3303–3325

Carter-Kent, C.; Zein, N.N.; Feldstein, A.E. Cytokines in the pathogenesis of fatty liver and disease

progression to steatohepatitis: Implications for treatment. Am. J. Gastroenterol. 2008, 103, 1036–

1042.
Evans, J.L.; Goldfine, I.D.; Maddux, B.A.; Grodsky, G.M. Are oxidative stress-activated signaling

pathways mediators of insulin resistance and -cell dysfunction? Diabetes 2003, 52, 1–8.

Bogdanova, K.; Poczatkova, H.; Uherkova, L.; Riegrova, D.; Rypka, M.; Feher, J.; Marchesini, G.;

Vesely, J. Non-alcoholic fatty liver disease (NAFLD)—A novel common aspect of the metabolic

syndrome. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2006, 150, 101–104.

Ye, X.; Feng, Y.; Tong, Y.; Ng, K.M.; Tsao, S.; Lau, G.K.; Sze, C.; Zhang, Y.; Tang, J.; Shen, J.; .

Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced

acute liver hepatotoxicity in rats. J. Ethnopharmacol. 2009, 124, 130–136.

Cheung, F.; Feng, Y.B.; Wang, N.; Yuen, M.F.; Tong, Y.; Wong, V.T. Effectiveness of Chinese herbal

medicine in treating liver fibrosis: A systematic review and meta-analysis of randomized

controlled trials. Chin. Med. 2012, 7

O'Brien RD. (1976) Acetylcholinesterase and its inhibition. In: Insecticide Biochemistry and Physiology.

Winkinson CF. (Ed.), Plenum Press, New York, 271-296.

Abou-Donia MB. (1981) Organophosphorus ester-induced delayed neurotoxicity. Ann Rev Pharmacol

Toxicol 21:511-548

Hussain MA, Matin MA. (1986 a) Cerebral glycolysis and glycogenolysis in diazinon treated animals.

Arh Hig Rada Toksikol 37: 29-34.

Fenichel GM, Dettbarn WD, Newmann TM. (1974) An experimental myopathy secondary to excessive

acetylcholine release. Neurology 24: 41-45.

Steeno OP, Pangkahila A. (1984) Occupational influences on male fertility and sexuality. Andrologia 16:

5-22.
Georgian L. (1975) The comparative cytogenetic effects of aldrin and phosphamidon. Mat Res 31: 103-

108.

Venkat JA, Shanti S, Davis K, Nayak M. Plimmer JR, Pfeil R, Nair PP. (1995) Relative genotoxic

activities of pesticides evaluated by a modified SOS microplate assay. Environ Mol Mutagen 25:

67-76

Tsatsakis AM, Aguridakis P, Michalodimitrakis MN, Tsakalov AK, Alegakis AK, Koumantakls E,

Troulakis G. (1996) Experiences with acute organophosphate poisonings in Crete. Vet Hum

Toxicol 38: 101-107.

Lee IP, Dixon RL. (1978) Factors influencing reproduction and genetic toxic effects on male gonads.

Environ Health Perspec 24: 111-127

USEPA: United States Environmental Protection Agency (1994) Integrated Risk Information System

(IRIS) on Dichlorvos. Environmental Criteria and Assessment Office, Office of Health and

Environmental Assessment, Office of Research and Development, Cincinnati, OH

FAO/UNEP. (1992). Dichlorvos draft decision guidance document prepared for FAO/UNEP joint group

of experts in PIC.FAO, Rome.

Harlin, K.S. and Dellinger, J.A. (1993). Retina, brain and blood cholinesterase levels in cats treated with

oral Dichlorvos . Vet. Hum. Toxicol.,35:201-203

Olinski R, Walter Z, Wiaderkiewicz R, Lukasova E, Palecek E. (1980) Changes in DNA properties due

to treatment witli tlie pesticides malathion and DDVP. Radiat Environ Biophys 18: 65-72.

Ni Z, Li S, Liu Y, Tang Y, Pang D. (1993) hiduction of micronucleus by organophosphorus pesticides

both in vivo and in vitro. Hua Hsi Ko Ta Hsiteh Hstieh Pao 24: 82-86.
Herrera E. and Barbas C. (2001).Vitamin E: action, metabolism and perspectives. J Physiol Biochem 57

(2): 43 – 56.

Wells W., Xu D., Yang Y., Rocque P. (1990). "Mammalian thioltransferase (glutaredoxin) and protein

disulfide isomerase have dehydroascorbate reductase activity". J Biol Chem 265 (26): 15361 – 4.

Smirnoff N. (2001). "L-ascorbic acid biosynthesis". Vitam Horm 61: 241 – 66.

Dewick P.M. (1995). The Biosynthesis of Shikimate Metabolites, Natural Product Reports 12:579-607

Rice-Evans C.A.; Miller N.J. and Paganga, G. (1997). Structure –antioxidant activity relationships of

flavonoids and phenolic acids. Trends in Plant Science 2:152-159.

Cai, Q.; Rahn R.O. and Zhang R. (1997). Oncogens and their roles in carcinogenesis. Cancer Lett. 119:

99-107.

Philipson JD., Natural products as basis for new drugs, Trends in pharmacology scienccs, 1980; 1:81-85.

Lin, C.C., Chen Y.L., Lin, J.M., Ujiie, T.: Am J Chin Med, 25(2): 153–161(1997).

Shinde, V., Dhalwal, K., Mahadik, K.R.: Pharmacologyonline News Letter 2: 1-11 (2007).

Ahmed, S.M., Swamy Bm, V., Gopkumar, P., R Dhanapal, R., Chandrashekara, V.M.: IJPT, 4: 22-28

(2005)

Ta-Chen, L and Feng L.H.: J. Chin. Chem. Soc., 46: 2-12( 1991).

P. S. Chen, J.H. Li and .C. Liu., :Cancer Lett. 152:112-115(2000).

Yun-Lian, L.,Yueh-Hsiung, K., Ming-Shi, S., Chien-Chih, C., Jun- Chih,O: J. Chin Chem Soc, 47: 253-

256(2000).

Oliveira, , J.T.A., Vasconcelos, I.M., Bezerra, L.C.N.M., Silveira, S.B., Monteiro, A.C.O., Moreira

R.A.:Food Chem, 70: 185-191 (2000).


Jing GAO Huan Dou, Xin-Hui Tang, Li-Zhi xu, Yi- Mei Fan, and Xiao-Ning Zhao :Acta Biochi Biophy

Sinica, 36: 767–772 (2004).

D.S. Mohale, A.P. Dewani , A.V. Chandewar , C.D.Khadse, A.S. Tripathi, S.S. Agrawal. 2009. Brief

Review On Medicinal Potential Of Terminalia Catappa. Journal of Herbal Medicine and

Toxicology 3 (1) 7-11